Krsnaa Diagnostics Ltd — earnings calls

Krsnaa Diagnostics reported Q1 FY27 revenue of INR2,355 million, up 22% year-on-year, with EBITDA margin at 25% compared to 27% in the prior-year quarter. Management attributed the margin compression to upfront manpower and logistics costs in the Rajasthan project ahead of full revenue realization, while stating the like-to-like business maintained stable margins. Retail business revenue grew 64% year-on-year to INR193 million, and the company was awarded a new Himachal Pradesh CT scan project covering 34 centers.

Krsnaa Diagnostics reported FY26 revenue of approximately INR7,728 million with EBITDA margin of around 28% and reported PAT of approximately INR1,014 million, crossing INR1,000 million in PAT for the first time. Management said Q4 revenue grew about 4% year-on-year with EBITDA margin of 29%, while DSO improved from 155 days to 139 days during the quarter. Management outlined plans for Rajasthan ramp-up, retail scale-up, and further capital investment of INR5,000 million in FY27.